What is The Jackson Laboratory?
Operating at the intersection of basic science and clinical application, The Jackson Laboratory is a global leader in the development of specialized mouse models, stem cell systems, and sophisticated data-driven analytical tools. By providing the essential biological resources required for studying complex human conditions—including cancer, neurological disorders, and the mechanisms of aging—the institution serves as a critical backbone for the international scientific community. Its market position is defined by its unique nonprofit status, which allows it to prioritize long-term research outcomes and the democratization of scientific data over short-term commercial gains, effectively bridging the gap between laboratory bench and bedside treatment.
How much funding has The Jackson Laboratory raised?
The Jackson Laboratory has raised a total of $87M across 4 funding rounds:
Unspecified
$58M
Unspecified
$6M
Unspecified
$10.5M
Unspecified
$12.5M
Unspecified (2011): $58M with participation from National Institutes of Health
Unspecified (2017): $6M led by National Institute of General Medical Sciences
Unspecified (2017): $10.5M supported by National Institutes of Health
Unspecified (2018): $12.5M featuring Maine Technology Institute
Key Investors in The Jackson Laboratory
National Institutes of Health
The National Institutes of Health is the primary agency of the United States government responsible for biomedical and health-related research, providing essential backing for large-scale scientific endeavors.
Maine Technology Institute
Maine Technology Institute is a state-funded organization that provides grants and equity investments to foster innovation and economic growth within Maine's technology and research sectors.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences supports fundamental research to enhance the understanding of biological processes, which is critical for advancements in disease diagnosis and prevention.
What's next for The Jackson Laboratory?
With the deployment of this recent capital, The Jackson Laboratory is positioned to accelerate its research initiatives and expand its technological capabilities. The strategic focus will likely center on scaling its genomic data platforms and enhancing the precision of its disease-modeling systems. By leveraging these resources, the institution aims to deepen its understanding of genetic architecture, thereby facilitating more targeted therapeutic interventions. As the organization continues to navigate the evolving landscape of biomedical innovation, its focus remains on maintaining its status as a foundational pillar for global health research, ensuring that its proprietary models and data sets remain accessible to the researchers tasked with solving the most pressing medical challenges of the 21st century.
See full The Jackson Laboratory company page
